- Home
- RDY vs ASND Comparison
RDY vs ASND Comparison
Compare RDY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- ASND
- Stock Information
- Founded
- RDY 1984
- ASND 2006
- Country
- RDY India
- ASND Denmark
- Employees
- RDY N/A
- ASND N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- RDY Health Care
- ASND Health Care
- Exchange
- RDY Nasdaq
- ASND Nasdaq
- Market Cap
- RDY 11.6B
- ASND 12.2B
- IPO Year
- RDY N/A
- ASND 2015
- Fundamental
- Price
- RDY $13.93
- ASND $206.34
- Analyst Decision
- RDY Strong Buy
- ASND Strong Buy
- Analyst Count
- RDY 1
- ASND 17
- Target Price
- RDY $16.90
- ASND $245.76
- AVG Volume (30 Days)
- RDY 1.1M
- ASND 515.3K
- Earning Date
- RDY 10-24-2025
- ASND 11-12-2025
- Dividend Yield
- RDY 0.51%
- ASND N/A
- EPS Growth
- RDY 9.95
- ASND N/A
- EPS
- RDY 0.79
- ASND N/A
- Revenue
- RDY $3,851,623,984.00
- ASND $758,592,045.00
- Revenue This Year
- RDY $6.29
- ASND $104.98
- Revenue Next Year
- RDY $2.61
- ASND $79.91
- P/E Ratio
- RDY $17.71
- ASND N/A
- Revenue Growth
- RDY 14.10
- ASND 97.46
- 52 Week Low
- RDY $12.26
- ASND $118.03
- 52 Week High
- RDY $16.17
- ASND $219.30
- Technical
- Relative Strength Index (RSI)
- RDY 50.51
- ASND 53.58
- Support Level
- RDY $13.79
- ASND $188.07
- Resistance Level
- RDY $14.02
- ASND $202.41
- Average True Range (ATR)
- RDY 0.22
- ASND 8.66
- MACD
- RDY 0.04
- ASND 0.10
- Stochastic Oscillator
- RDY 52.81
- ASND 54.88
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.